CHIEF SENIOR RESEARCHER, TUBITAK MAM, GENETIC ENGINEERING AND BIOTECHNOLOGY INSTITUTE (GEBI)
The Genetic Engineering and Biotechnology Institute (GEBI) conducts researches and develops technologies in the field of genetic engineering and biotechnology with high added value by taking into consideration the developments in the world and the needs of the public and industrial sectors in Turkey.
TR-PHARM, founded in 2013, is a marketer of pharmaceuticals and biopharmaceuticals with a focus on high-tech R&D and the ambition to gain global recognition in bringing high-quality and cost-effective solutions in the healthcare industry.
Active since 1958, DEVA is a generics company with approximately 600 products ranging from APIs, formulations, sterile injectables and ampoules, BFS eye drops and animal health products.
Ontario Mining and Toronto’s Finance Hub 2026 - Pre-Release
2025 was a year of change for Ontario’s mining industry. Canada’s evolving international relationships heightened the focus on economic sovereignty, while federal and provincial elections brought critical minerals to the forefront of policy discussions. The provincial government’s ‘One Project, One Process’ framework aims to reduce permitting delays, as critical mineral prices show early signs of recovery from a prolonged weak cycle.